相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Clinical spectrum of individuals with pathogenic NF1 missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype-phenotype study in neurofibromatosis type 1
Magdalena Koczkowska et al.
HUMAN MUTATION (2020)
Multisystem burden of neurofibromatosis 1 in Denmark: registry- and population-based rates of hospitalizations over the life span
Line Kenborg et al.
GENETICS IN MEDICINE (2020)
Neurofibromatosis type 1 of the child increases birth weight
Jussi Leppavirta et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2019)
Human Gain-of-Function MC4R Variants Show Signaling Bias and Protect against Obesity
Luca A. Lotta et al.
CELL (2019)
Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls
Jason Flannick et al.
NATURE (2019)
Increased resting metabolism in neurofibromatosis type 1
Marcio Leandro Ribeiro de Souza et al.
CLINICAL NUTRITION ESPEN (2019)
Prevalence of neurofibromatosis type 1 in the Finnish population
Roope A. Kallionpaa et al.
GENETICS IN MEDICINE (2018)
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
Yan Zheng et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
RAS signalling in energy metabolism and rare human diseases
L. Dard et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2018)
Increased insulin sensitivity in individuals with neurofibromatosis type 1
Aline Stangherlin Martins et al.
ARCHIVES OF ENDOCRINOLOGY METABOLISM (2018)
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Angli Xue et al.
NATURE COMMUNICATIONS (2018)
Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps
Anubha Mahajan et al.
NATURE GENETICS (2018)
Birth Weight and Risk of Type 2 Diabetes Mellitus, Cardiovascular Disease, and Hypertension in Adults: A Meta-Analysis of 7 646 267 Participants From 135 Studies
Marianne Ravn Knop et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Absence of Neurofibromin Induces an Oncogenic Metabolic Switch via Mitochondrial ERK-Mediated Phosphorylation of the Chaperone TRAP1
Ionica Masgras et al.
CELL REPORTS (2017)
The Genetic Architecture of Type 1 Diabetes
Samuel T. Jerram et al.
GENES (2017)
Neurofibromatosis type 1
David H. Gutmann et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Type 1 diabetes genome-wide association studies: not to be lost in translation
Flemming Pociot
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2017)
The Influence of Type 1 Diabetes Genetic Susceptibility Regions, Age, Sex, and Family History on the Progression From Multiple Autoantibodies to Type 1 Diabetes: A TEDDY Study Report
Jeffrey P. Krischer et al.
DIABETES (2017)
Lower fasting blood glucose in neurofibromatosis type 1
Aline Stangherlin Martins et al.
ENDOCRINE CONNECTIONS (2016)
Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1
Elina Uusitalo et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Understanding Growth Failure in Costello Syndrome: Increased Resting Energy Expenditure
Chiara Leoni et al.
JOURNAL OF PEDIATRICS (2016)
Genetic risk factors for type 1 diabetes
Flemming Pociot et al.
LANCET (2016)
Incidence and Mortality of Neurofibromatosis: A Total Population Study in Finland
Elina Uusitalo et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Nutrient intake in neurofibromatosis type 1: A cross-sectional study
Marcio Leandro Ribeiro de Souza et al.
NUTRITION (2015)
Neurofibromatosis type 1 and chronic neurological conditions in the United States: an administrative claims analysis
Chinwe C. Madubata et al.
GENETICS IN MEDICINE (2015)
Overlap of Genetic Susceptibility to Type 1 Diabetes, Type 2 Diabetes, and Latent Autoimmune Diabetes in Adults
Kevin J. Basile et al.
CURRENT DIABETES REPORTS (2014)
Type 2 diabetes susceptibility gene variants predispose to adult-onset autoimmune diabetes
Mette K. Andersen et al.
DIABETOLOGIA (2014)
Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes
Valgerdur Steinthorsdottir et al.
NATURE GENETICS (2014)
Loss-of-function mutations in SLC30A8 protect against type 2 diabetes
Jason Flannick et al.
NATURE GENETICS (2014)
LEOPARD syndrome-associated SHP2 mutation confers leanness and protection from diet-induced obesity
Mylene Tajan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Neurofibromatosis type 1 and pregnancy complications: a population-based study
Anna R. Terry et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2013)
Health and Quality of Life in Adults with Noonan Syndrome
Gerhard Binder et al.
JOURNAL OF PEDIATRICS (2012)
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes
Andrew P. Morris et al.
NATURE GENETICS (2012)
Genetics of the HLA Region in the Prediction of Type 1 Diabetes
Janelle A. Noble et al.
CURRENT DIABETES REPORTS (2011)
Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989
D. Gareth R. Evans et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2011)
Mortality associated with neurofibromatosis type 1: A study based on Italian death certificates (1995-2006)
Maria Masocco et al.
ORPHANET JOURNAL OF RARE DISEASES (2011)
Type 2 diabetes as an inflammatory disease
Marc Y. Donath et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Finding the missing heritability of complex diseases
Teri A. Manolio et al.
NATURE (2009)
Signals from the neural crest regulate beta-cell mass in the pancreas
Nada Nekrep et al.
DEVELOPMENT (2008)
Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes
Julius Gudmundsson et al.
NATURE GENETICS (2007)
Mortality in neurofibromatosis 1: An analysis using US death certificates
SA Rasmussen et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)